Aqueous extract of Taxus Chinensis (Pilger) Rehd inhibits lung carcinoma A549 cells through the epidermal growth factor receptor/mitogen-activated protein kinase pathway in vitro and in vivo-Reference-Cited by-同舟云学术

Aqueous extract of Taxus Chinensis (Pilger) Rehd inhibits lung carcinoma A549 cells through the epidermal growth factor receptor/mitogen-activated protein kinase pathway in vitro and in vivo

Published:2014-06 Issue:3 Volume:34 Page:293-301
ISSN:0254-6272
Container-title:Journal of Traditional Chinese Medicine
language:en
Short-container-title:Journal of Traditional Chinese Medicine

Author:

Shu Qijin,Shen Minhe,Wang Binbin,Cui Qingli,Zhou Xiaoying,Zhu Luming

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Lung cancer in never smokers — a different disease;Sun;Nat Rev Cancer,2007

2. Considerations for second-line therapy of non-small cell lung cancer;Stinchcombe;Oncologist,2008

3. Lung cancer: progress in diagnosis, staging and therapy;Spiro;Respirology,2010

4. One hundred years of lung cancer;Spiro;Am J Respir Crit Care Med,2005

5. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis;Hirsch;J Clin Oncol,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer;Medicine;2023-11-03

2. Aqueous extract of Taxus chinensis var. mairei targeting CD47 enhanced antitumor effects in non-small cell lung cancer;Biomedicine & Pharmacotherapy;2022-10

3. Plants in Anticancer Drug Discovery: From Molecular Mechanism to Chemoprevention;BioMed Research International;2022-03-02

4. Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro;Biomedicine & Pharmacotherapy;2021-06

5. Current status and future prospects of p38α/MAPK14 kinase and its inhibitors;European Journal of Medicinal Chemistry;2021-03